Cullinan Therapeutics (CGEM) Change in Taxes (2022 - 2023)
Cullinan Therapeutics (CGEM) posted quarterly Change in Taxes of -$4.2 million for Q2 2023, down 109.05% year-over-year from $46.5 million in Q2 2022, and down 5509.33% quarter-over-quarter from -$75000.0 in Q1 2023.
Powered by 
Analysis
Cullinan Therapeutics (CGEM) Change in Taxes (2022 - 2023) Analysis & Trends
Cullinan Therapeutics' Change in Taxes history runs 2 years deep, the most recent figure standing at -$4.2 million for Q2 2023.
- In Q2 2023, Change in Taxes fell 109.05% year-over-year to -$4.2 million; the TTM figure through Mar 2024 stood at -$4.2 million (down 200.0% YoY), while the FY2023 annual figure was -$4.3 million, down 200.0% from the prior year.
- Change in Taxes for Q2 2023 stood at -$4.2 million, down from -$75000.0 in the prior quarter.
- The five-year high for Change in Taxes was $46.5 million in Q2 2022, with the low at -$35.1 million in Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Cullinan Therapeutics | 1.37 Bn | 1.37 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -4.21 Mn |
| Mar 31, 2023 | -75,000.00 |
| Dec 31, 2022 | -7.12 Mn |
| Sep 30, 2022 | -35.10 Mn |
| Jun 30, 2022 | 46.50 Mn |